Thyrocare Technologies Ltd
Thyrocare Tech. | 539871
Stock Charts
No Information Available
Stock charts information is not available at this time.
Stock Performance
Ratios
About Company
- Thyrocare Technologies Limited was incorporated in January, 2000
- The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India
- As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring
- Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests
- The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs)
- The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions
- Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of Thyrocare Technologies, is engaged in PET-CT Scan imaging diagnostic business
- NHL currently has 10 active operating PET-CT scanners in 8 imaging centers: two in Navi Mumbai, two in New Delhi, one each in Hyderabad, Central Mumbai, Western Mumbai, Baroda, Nashik and Bangalore
- NHL also owns and operates a medical cyclotron unit in Navi Mumbai, which produces the radioactive biomarker FDG required for PET-CT scanning
- Thyrocare Technologies CPL, which is located in Navi Mumbai, is equipped with automated systems, diagnostic testing instruments and processes from leading international and Indian healthcare brands
Ethics: Thyrocare Technologies Ltd is flagged for
Adequate
---
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *

Top Gainers
Frequently Asked Questions
What is Share Price of Thyrocare Technologies Ltd?
The current share price of Thyrocare Technologies Ltd (Thyrocare Tech.) is ₹521.65. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Thyrocare Technologies Ltd?
The Price-to-Earnings (P/E) ratio of Thyrocare Technologies Ltd is 521.65. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd has a 52-week high of ₹536.66 and a 52-week low of ₹291.36. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Thyrocare Technologies Ltd?
The Earnings Per Share (EPS) of Thyrocare Technologies Ltd is ₹10.53. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd has a Return on Equity (ROE) of 18.23%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
